Follow
A. Ruklanthi de Alwis
A. Ruklanthi de Alwis
Duke-NUS Medical School
Verified email at duke-nus.edu.sg
Title
Cited by
Cited by
Year
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
R De Alwis, SA Smith, NP Olivarez, WB Messer, JP Huynh, ...
Proceedings of the National Academy of Sciences 109 (19), 7439-7444, 2012
4502012
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection
R de Alwis, M Beltramello, WB Messer, S Sukupolvi-Petty, WMPB Wahala, ...
PLoS neglected tropical diseases 5 (6), e1188, 2011
2542011
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
G Fibriansah, JL Tan, SA Smith, R De Alwis, TS Ng, VA Kostyuchenko, ...
Nature communications 6 (1), 6341, 2015
2102015
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
S Kalimuddin, CYL Tham, M Qui, R de Alwis, JXY Sim, JME Lim, HC Tan, ...
Med 2 (6), 682-688. e4, 2021
1932021
A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
G Fibriansah, JL Tan, SA Smith, AR de Alwis, TS Ng, VA Kostyuchenko, ...
EMBO molecular medicine 6 (3), 358-371, 2014
1882014
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera
R De Alwis, KL Williams, MA Schmid, CY Lai, B Patel, SA Smith, ...
PLoS pathogens 10 (10), e1004386, 2014
1842014
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
R De Alwis, S Chen, ES Gan, EE Ooi
EBioMedicine 55, 2020
1632020
Natural strain variation and antibody neutralization of dengue serotype 3 viruses
WMPB Wahala, EF Donaldson, R de Alwis, MA Accavitti-Loper, RS Baric, ...
PLoS pathogens 6 (3), e1000821, 2010
1622010
The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein
SA Smith, AR de Alwis, N Kose, E Harris, KD Ibarra, KM Kahle, JM Pfaff, ...
MBio 4 (6), 10.1128/mbio. 00873-13, 2013
1532013
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
R De Alwis, ES Gan, S Chen, YS Leong, HC Tan, SL Zhang, C Yau, ...
Molecular Therapy 29 (6), 1970-1983, 2021
1392021
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
WB Messer, R De Alwis, BL Yount, SR Royal, JP Huynh, SA Smith, ...
Proceedings of the National Academy of Sciences 111 (5), 1939-1944, 2014
1302014
Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional …
SA Smith, AR de Alwis, N Kose, RS Jadi, AM de Silva, JE Crowe Jr
Journal of virology 88 (21), 12233-12241, 2014
982014
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals
AT Tan, JME Lim, N Le Bert, K Kunasegaran, A Chia, MDC Qui, N Tan, ...
The Journal of clinical investigation 131 (17), 2021
922021
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics
SA Smith, R De Alwis, N Kose, AP Durbin, SS Whitehead, AM De Silva, ...
The Journal of infectious diseases 207 (12), 1898-1908, 2013
882013
Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype
R de Alwis, DJ Bangs, MA Angelo, C Cerpas, A Fernando, J Sidney, ...
Journal of virology 90 (9), 4771-4779, 2016
732016
Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site
SA Smith, UK Nivarthi, R de Alwis, N Kose, G Sapparapu, R Bombardi, ...
Journal of virology 90 (2), 780-789, 2016
582016
A cross-sectional seroepidemiological survey of typhoid fever in Fiji
CH Watson, S Baker, CL Lau, K Rawalai, M Taufa, J Coriakula, ...
PLoS neglected tropical diseases 11 (7), e0005786, 2017
512017
Differential immunogenicity of homologous versus heterologous boost in Ad26. COV2. S vaccine recipients
NKH Khoo, JME Lim, US Gill, R de Alwis, N Tan, JZN Toh, JE Abbott, ...
Med 3 (2), 104-118. e4, 2022
462022
No clinical benefit of empirical antimicrobial therapy for pediatric diarrhea in a high-usage, high-resistance setting
VT Duong, HT Tuyen, P Van Minh, JI Campbell, HL Phuc, TDH Nhu, ...
Clinical Infectious Diseases 66 (4), 504-511, 2018
442018
Functional transplant of a dengue virus serotype 3 (DENV3)-specific human monoclonal antibody epitope into DENV1
WB Messer, BL Yount, SR Royal, R de Alwis, DG Widman, SA Smith, ...
Journal of virology 90 (10), 5090-5097, 2016
402016
The system can't perform the operation now. Try again later.
Articles 1–20